My ePortfolio Register   
The First Targeted Personalised Cancer Medicines

The First Targeted Personalised Cancer Medicines

en English

Only available as part of a course
Proceed to module  Shortlist  Rate Module  Share

en English

Summary A short lecture on the First Targeted Personalised Cancer Medicines

Prof Gordon McVie of European Institute of Oncology in Milan, Italy gives a short lecture on First Targeted Personalised Cancer Medicines.

Target Audience

Healthcare professionals and researchers wishing to expand on their knowledge of Personalised Medicine.

Learning Objectives

By the end of this module, you should be able to:

  • Understand what oncogenes are in the context of the genome.
  • Understand the role of targeted cancer therapies in tumour growth.
  • Realise why targeted therapies are only appropriate for certain oncogenes.
  • Learn the different types of targeted therapies.
  • Recognise the challenge of personalised medicine in this context.
Only available as part of course(s):

Personalised Medicine

Proceed to Module

Relevant to the following professions

  • Nurse
  • Oncologist
  • Other
  • Public Health
  • Researcher
Proceed to module  Shortlist  Rate Module

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence